Barbara Tate

2.1k total citations
42 papers, 1.6k citations indexed

About

Barbara Tate is a scholar working on Physiology, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Barbara Tate has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 16 papers in Molecular Biology and 10 papers in Endocrine and Autonomic Systems. Recurrent topics in Barbara Tate's work include Alzheimer's disease research and treatments (22 papers), Circadian rhythm and melatonin (9 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). Barbara Tate is often cited by papers focused on Alzheimer's disease research and treatments (22 papers), Circadian rhythm and melatonin (9 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). Barbara Tate collaborates with scholars based in United States, Australia and Denmark. Barbara Tate's co-authors include Ronald E. Majocha, Gary S. Richardson, Mary A. Carskadon, Christine Acebo, Ronald Seifer, Robert A. Parker, R E Strecker, Stephanie E. Gaus, Clifford B. Saper and David G. Harper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Neuroscience.

In The Last Decade

Barbara Tate

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Tate United States 20 544 525 477 432 353 42 1.6k
Leah Aluisio United States 24 533 1.0× 91 0.2× 568 1.2× 398 0.9× 473 1.3× 32 1.7k
Matthew D. Troyer United States 19 302 0.6× 691 1.3× 643 1.3× 245 0.6× 751 2.1× 34 2.9k
Meihua Deng United States 8 393 0.7× 405 0.8× 125 0.3× 104 0.2× 232 0.7× 9 985
Florian Holsboer Germany 20 293 0.5× 236 0.4× 204 0.4× 152 0.4× 385 1.1× 33 2.1k
Mauro Corsi Italy 26 413 0.8× 280 0.5× 595 1.2× 195 0.5× 864 2.4× 65 2.2k
Joanne Allard United States 21 372 0.7× 989 1.9× 312 0.7× 179 0.4× 678 1.9× 33 2.2k
Jonathan Shelton United States 16 560 1.0× 302 0.6× 576 1.2× 449 1.0× 488 1.4× 22 1.7k
W. Joseph Herring United States 26 992 1.8× 270 0.5× 1.4k 2.9× 1.3k 3.0× 469 1.3× 55 2.6k
Karen Schmitt Switzerland 12 283 0.5× 430 0.8× 144 0.3× 126 0.3× 451 1.3× 18 1.1k
Samuel G. Speciale United States 25 209 0.4× 326 0.6× 472 1.0× 118 0.3× 581 1.6× 49 1.9k

Countries citing papers authored by Barbara Tate

Since Specialization
Citations

This map shows the geographic impact of Barbara Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Tate more than expected).

Fields of papers citing papers by Barbara Tate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Tate. The network helps show where Barbara Tate may publish in the future.

Co-authorship network of co-authors of Barbara Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Tate. A scholar is included among the top collaborators of Barbara Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Tate. Barbara Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martens, Lauren Herl, et al.. (2024). Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease. Journal of Neuroinflammation. 21(1). 37–37. 7 indexed citations
2.
Hodgson, Robert A., Brian K. Kennedy, Eliezer Masliah, et al.. (2019). Aging: therapeutics for a healthy future. Neuroscience & Biobehavioral Reviews. 108. 453–458. 20 indexed citations
3.
Skelton, Rachel L., Jon M. Kornhauser, & Barbara Tate. (2015). Personalized medicine for pathological circadian dysfunctions. Frontiers in Pharmacology. 6. 125–125. 7 indexed citations
4.
Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2015). Minimization of drug–drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 25(7). 1621–1626. 6 indexed citations
5.
Loureiro, Robyn, Jo Ann Dumin, Timothy D. McKee, et al.. (2013). Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models. Alzheimer s Research & Therapy. 5(2). 19–19. 20 indexed citations
6.
Sprouse, Jeffrey, Linda Reynolds, Robin J. Kleiman, et al.. (2010). Chronic treatment with a selective inhibitor of casein kinase I δ/ε yields cumulative phase delays in circadian rhythms. Psychopharmacology. 210(4). 569–576. 23 indexed citations
7.
Lanz, Thomas A., Kathleen M. Wood, K. Richter, et al.. (2010). Pharmacodynamics and Pharmacokinetics of the γ-Secretase Inhibitor PF-3084014. Journal of Pharmacology and Experimental Therapeutics. 334(1). 269–277. 39 indexed citations
8.
Menniti, Frank S., JingMei Ren, Timothy Coskran, et al.. (2009). Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism. Journal of Pharmacology and Experimental Therapeutics. 331(3). 842–850. 33 indexed citations
9.
Morris, Luc G.T. & Barbara Tate. (2007). Phase Response Curve to Melatonin in a Putatively Diurnal Rodent,Octodon degus. Chronobiology International. 24(3). 407–411. 10 indexed citations
10.
Badura, Lori L., Terri A. Swanson, Wendy O. Adamowicz, et al.. (2007). An Inhibitor of Casein Kinase Iϵ Induces Phase Delays in Circadian Rhythms under Free-Running and Entrained Conditions. Journal of Pharmacology and Experimental Therapeutics. 322(2). 730–738. 135 indexed citations
11.
Du, Ping, Kathleen M. Wood, Michele H. Rosner, et al.. (2007). Dominance of Amyloid Precursor Protein Sequence over Host Cell Secretases in Determining β-Amyloid Profiles Studies of Interspecies Variation and Drug Action by Internally Standardized Immunoprecipitation/Mass Spectrometry. Journal of Pharmacology and Experimental Therapeutics. 320(3). 1144–1152. 18 indexed citations
12.
Gaus, Stephanie E., R E Strecker, Barbara Tate, Robert A. Parker, & Clifford B. Saper. (2002). Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience. 115(1). 285–294. 189 indexed citations
13.
Carskadon, Mary A., William C. Dement, Sanford M. Dornbusch, et al.. (2001). Adolescent Sleep Patterns. Cambridge University Press eBooks. 52 indexed citations
14.
Ourednik, Václav, Jitka Ourednik, Kook I. Park, et al.. (2000). Neural Stem Cells Are Uniquely Suited for Cell Replacement and Gene Therapy in the CNS. Novartis Foundation symposium. 231. 242–269. 29 indexed citations
15.
Stopa, Edward G., Ladislav Volicer, V. Kuo-LeBlanc, et al.. (1999). Pathologic Evaluation of the Human Suprachiasmatic Nucleus in Severe Dementia. Journal of Neuropathology & Experimental Neurology. 58(1). 29–39. 211 indexed citations
16.
Moser, David J., Ronald A. Cohen, Matthew M. Clark, et al.. (1999). Neuropsychological Functioning Among Cardiac Rehabilitation Patients. Journal of Cardiopulmonary Rehabilitation. 19(2). 91–97. 51 indexed citations
17.
Newton, Julie, et al.. (1998). Indomethacin Reverses the Microglial Response to Amyloid β-Protein. Neurobiology of Aging. 19(3). 201–204. 82 indexed citations
18.
Walcott, Elisabeth C. & Barbara Tate. (1996). Entrainment of Aged, Dysrhythmic Rats to a Restricted Feeding Schedule. Physiology & Behavior. 60(5). 1205–1208. 18 indexed citations
19.
Majocha, Ronald E., Barbara Tate, & Charles A. Marotta. (1993). PC12 cells release stimulatory factors after transfection with β/A4-C-terminal DNA of the Alzheimer amyloid precursor protein. Molecular and Chemical Neuropathology. 18(1-2). 99–113. 3 indexed citations
20.
Maestre, Gladys E., Barbara Tate, Ronald E. Majocha, & Charles A. Marotta. (1992). Cell surface extensions associated with overexpression of Alzheimer ß/A4 amyloid. Brain Research. 599(1). 64–72. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026